Psychology, Therapy and Mental Health Resources from the Team at CounsellingResource.com

Psychology, Philosophy & Real Life

‘Medications’ at Psychology, Philosophy and Real Life, Page 4

The following articles are related to ‘Medications’ at Psychology, Philosophy and Real Life.

This list is sorted chronologically, from newest back to earliest.

CBT as Effective for Sleep Problems as Medications Like Ambien

By Dr Greg Mulhauser, Managing Editor

No, that’s not to say that CBT will put you to sleep! Rather, an article carried on the APA’s PsycPort highlights studies indicating that cognitive behavioural therapy can improve sleep about as well as drugs can. According to the article, not only can talk therapy such as CBT help with sleeping problems, but its effects continue for many months — unlike the effects of drugs, where effectiveness is not known to continue after discontinuing the medication.

Mixed Messages on ADHD Drugs Side Effects

By Dr Greg Mulhauser, Managing Editor

Last week, an FDA advisory committee voted to recommend adding ‘black box’ safety warnings to ADHD drugs. This week, the director of the FDA’s division of psychiatry products says it would be unusual for the agency to issue a ‘black box’ warning based on such thin evidence. A second FDA committee, which focuses on pediatrics, will consider the drugs’ safety next month.

Black Box Warnings for Ritalin and Other ADHD Drugs

By Dr Greg Mulhauser, Managing Editor

It’s official: an FDA science advisory committee has voted to recommend the most serious type of ‘black box’ warning labels for Ritalin and other stimulants used in the treatment of attention deficit hyperactivity disorder.

FDA Reports on Deaths from ADHD Drugs

By Dr Greg Mulhauser, Managing Editor

Twenty-five people died suddenly and another 54 suffered serious cardiovascular problems after taking drugs to treat attention deficit hyperactivity disorder between 1999 and 2003, according to a report from the US government’s Food and Drug Administration. The report says that children accounted for 19 of the deaths and 26 of the cases of nonfatal cardiovascular problems, including heart attack, stroke, hypertension, palpitations and arrhythmia.

ADHD Patch to be Sold as Daytrana

By Dr Greg Mulhauser, Managing Editor

The US Food and Drug Administration has indicated it will approve a patch for treating attention deficit hyperactivity disorder in children, provided that the manufacturers agree to certain changes in how the ADHD patch will be labelled and agree to monitor the product once it is on the market.

Page 4 of 4 1 2 3 4